A randomised double blind controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

被引：1
|
作者：
Leiper, K
Woolner, JT
Parker, TJ
van der Vleit, M
Mullan, MM
Fear, S
Rhodes, JM
Hunter, JO
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Acad Hosp, Cambridge, England
[3] Roy Castle Int Ctr Lung Canc Res, Liverpool, Merseyside, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84470-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3032
引用
收藏
页码：A583 / A583
页数：1
相关论文
共 50 条
  • [41] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [42] Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial
    Reuter, Uwe
    Ehrlich, Marc
    Gendolla, Astrid
    Heinze, Axel
    Klatt, Jan
    Wen, Shihua
    Hours-Zesiger, Peggy
    Nickisch, Jacqueline
    Sieder, Christian
    Hentschke, Christian
    Maier-Peuschel, Monika
    CEPHALALGIA, 2022, 42 (02) : 108 - 118
  • [43] VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis
    Schreiber, Stefan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Sands, Bruce E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S612 - S613
  • [44] Budesonide CIR is more effective than mesalazine in active Crohn's disease. A 16 week, international, randomized, double-blind multicentre trial
    Thomsen, OO
    Cortot, A
    Jewell, D
    Wright, JP
    Winter, T
    Veloso, FT
    Vatn, M
    Persson, T
    Pettersson, E
    GUT, 1997, 41 : A70 - A70
  • [45] A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING CYSTEAMINE IN HUNTINGTON'S DISEASE
    Bonneau, Dominique
    Bachoud-Levi, Anne-Catherine
    Durr, Alexandra
    Goizet, Cyril
    Azulay, Jean-Philippe
    Simonin, Clemence
    Tranchant, Christine
    Calvas, Fabienne
    Krystkowiak, Pierre
    Olivier, Audrey
    Saudou, Frederic
    Maison, Patrick
    Allain, Philippe
    Verny, Christophe
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A101 - A102
  • [46] Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
    Ballard, C
    Margallo-Lana, M
    Juszczak, E
    Douglas, S
    Swann, A
    Thomas, A
    O'Brien, J
    Everratt, A
    Sadler, S
    Maddison, C
    Lee, L
    Bannister, C
    Elvish, R
    Jacoby, R
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7496): : 874 - 877
  • [47] Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
    van Rhee, Frits
    Wong, Raymond S.
    Munshi, Nikhil
    Rossi, Jean-Francois
    Ke, Xiao-Yan
    Fossa, Alexander
    Simpson, David
    Capra, Marcelo
    Liu, Ting
    Hsieh, Ruey Kuen
    Goh, Yeow Tee
    Zhu, Jun
    Cho, Seok-Goo
    Ren, Hanyun
    Cavet, James
    Bandekar, Rajesh
    Rothman, Margaret
    Puchalski, Thomas A.
    Reddy, Manjula
    van de Velde, Helgi
    Vermeulen, Jessica
    Casper, Corey
    LANCET ONCOLOGY, 2014, 15 (09): : 966 - 974
  • [48] Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. A double blind controlled study
    Haderslev, KV
    Tjellesen, L
    Sorensen, HA
    Staun, M
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S181 - S182
  • [49] Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease:: a randomised, double blind, placebo controlled GETAID trial
    Marteau, P.
    Lemann, M.
    Seksik, P.
    Laharie, D.
    Colombel, J. F.
    Bouhnik, Y.
    Cadiot, G.
    Soule, J. C.
    Bourreille, A.
    Metman, E.
    Lerebours, E.
    Carbonnel, F.
    Dupas, J. L.
    Veyrac, M.
    Coffin, B.
    Moreau, J.
    Abitbol, V.
    Blum-Sperisen, S.
    Mary, J. Y.
    GUT, 2006, 55 (06) : 842 - 847
  • [50] A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease
    Ingvar Bjarnason
    Guy Sission
    Bu’Hussaine Hayee
    Inflammopharmacology, 2019, 27 : 465 - 473
12345